AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22820371
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (active vitamin D analog compounds); specific dosage and duration not mentioned.
Trial: 8006401
Drug: Vasopressin plus
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vasopressin plus transdermal nitroglycerin
Trial: 3142634
Drug: Noxythiolin irrigation
RxNorm normalized name: noxythiolin Irrigation Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noxythiolin irrigation (2.5% solution)
Trial: 7874080
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy alone
Trial: 19880463
Drug: One-year treatment
RxNorm normalized name: segesterone
DrugBank: Segesterone (DB14584)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-year treatment continuation
Trial: 22710356
Drug: Beetroot (BR)
RxNorm normalized name: Respa-BR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot (BR) beverage, 500 ml daily for 6 days
Trial: 15237585
Drug: Alternating scheme
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating scheme (3 cycles of 5‐fluorouracil and leucovorin followed by pelvic radiotherapy and 3 weeks after radiation therapy, another 3 cycles of chemotherapy)
Trial: 22387644
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg orally 2 hours prior to surgery
Trial: 993925
Drug: High rate
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High rate of intravenous infusion (10.3 ml/kg/hr)
Trial: 2268740
Drug: Oyster shell
RxNorm normalized name: Oyster Shell
DrugBank: Ostrea edulis shell (DB14251)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oyster shell electrolysate (OSE) 900 mg/day
Trial: 28780466
Drug: Cisplatin 80
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 80 mg/m2 (GC80)
Trial: 28726022
Drug: On-medication condition
RxNorm normalized name: selenium sulfide
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: On-medication condition
Trial: 23718677
Drug: Dabigatran 150
RxNorm normalized name: dabigatran 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 150 mg twice daily
Trial: 14739817
Drug: Basal-bolus group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal-bolus group (8 ml/h basal, 4 ml bolus)
Trial: 8996292
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy for acute myocardial infarction
Trial: 31867651
Drug: Immediate nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate nicotine reduction to 0.04 mg nicotine/g of tobacco
Trial: 8318480
Drug: Topical ketanserin
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketanserin 0.5%
Trial: 20885202
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration (WBV) treatment at frequencies of 30, 35, 40, or 50 Hz and amplitudes of 2-4 or 4-6 mm for 1 minute.
Trial: 17900393
Drug: Group CBT
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group CBT (Cognitive Behavioral Therapy) targeting reduction of distress associated with hallucinations
Trial: 12591053
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (800 IU) and Vitamin C (1000 mg) supplementation
Trial: 10994883
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy only
Trial: 334216
Drug: Nomifensine 75
RxNorm normalized name: nomifensine
DrugBank: Nomifensine (DB04821)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nomifensine 75 mg with Clobazam 30 mg
Trial: 24118113
Drug: Twice-daily biphasic
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily biphasic insulin analogue (biphasic insulin aspart 70/30, biphasic insulin aspart 30)
Trial: 7123952
Drug: Beta-methyl-digoxin (BMD)
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Beta-methyl-digoxin (BMD) 0.5 mg
Trial: 11028253
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of methylphenidate HCl
Trial: 3522770
Drug: Weekly doses
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly doses of 900 mg of rifampin plus daily doses of 100 mg of dapsone
Trial: 21518554
Drug: Anti-thymocyte globulin
RxNorm normalized name: ANTI-THYMOCYTE GLOBULIN
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-thymocyte globulin (ATG) (9 mg/kg) given 2 hours before kidney transplantation
Trial: 31053134
Drug: Weekly incremental
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly incremental reductions in oral corticosteroid (OCS) dose
Trial: 29486796
Drug: Deworming treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deworming treatment
Trial: 24858376
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g TRP-rich protein hydrolysate
Trial: 30907817
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no heparin dose)
Trial: 29275371
Drug: Different dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different dual antiplatelet therapy durations and stent types
Trial: 9473217
Drug: Oral hydroxyurea
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hydroxyurea (80 mg/kg every 3 days)
Trial: 9473217
Drug: Intravenous hydroxyurea
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydroxyurea (2000 mg as a 30-minute infusion)
Trial: 12118641
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment during labour
Trial: 30358831
Drug: Control capsule
RxNorm normalized name: Azo Men Bladder Control Capsules(obs)
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control capsule (flavanol-free)
Trial: 9505567
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)
Trial: 19819634
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg kg(‐1) tramadol + 30 min later 0.05 mg kg(‐1) midazolam + 2 mg kg(‐1) ketamine
Trial: 11779098
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no r‐HuEPO treatment)
Trial: 30188953
Drug: Short-acting beta-agonists
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting beta-agonists (SABAs)
Trial: 30876431
Drug: Active tDCS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active tDCS (2 mA for 30 s) combined with upper limb physical therapy (20 min passive movement + 20 min active mini-bike) for 10 sessions.
Trial: 29944604
Drug: Ketone ester
RxNorm normalized name: Ketonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketone ester (KE) supplement (750 mg·kg)
Trial: 11155152
Drug: Interferon-alpha (IFN-alpha)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFN-alpha) at 3 MU thrice weekly (TIW) for 12 months
Trial: 30648919
Drug: PCV15 Formulation
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCV15 Formulation B
Trial: 26319158
Drug: Reuptake inhibitor
RxNorm normalized name: Dopamine reuptake inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reuptake inhibitor antidepressant medication (MED)
Trial: 30521662
Drug: Short dental
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short dental implants
Trial: 22401329
Drug: Weekly automated
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly automated telephone self-management (ATSM) support with nurse care management
Trial: 1971504
Drug: Interferon-alpha 18
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha 18 million U/d with zidovudine 100 mg every 4 hours
Trial: 1971504
Drug: Interferon-alpha 9
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha 9 million U/d with zidovudine 100 or 200 mg every 4 hours
Trial: 1971504
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with interferon-alpha and zidovudine
Trial: 26457099
Drug: Olea ointment
RxNorm normalized name: Olea europaea pollen
DrugBank: Olea europaea pollen (DB10378)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olea ointment
Trial: 7639972
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir 500 mg six times daily
Trial: 19061203
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment doses (specific doses not mentioned)
Trial: 1313951
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (mean of 11.2 g per day) for 3 months
Trial: 12631592
Drug: Neoadjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant therapy with docetaxel plus doxorubicin or paclitaxel
Trial: 27977721
Drug: Miconazole nitrate
RxNorm normalized name: Miconazole Nitrate
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole nitrate mucoadhesive tablets (10 mg) once daily for 14 days
Trial: 27514411
Drug: Ulinastatin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin treatment group
Trial: 2919769
Drug: No H2-antagonist
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No H2-antagonist (Control)
Trial: 17905178
Drug: Insulin Aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin Aspart (IAsp)
Trial: 7049099
Drug: Hypothermic potassium
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothermic potassium cardioplegia (cold crystalloid solution with 25 mEq/L potassium chloride)
Trial: 31923099
Drug: Keto acid
RxNorm normalized name: Branched-chain alpha-keto acid dehydrogenase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Keto acid (KA) supplement (0.1 g/kg/day)
Trial: 27896411
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (2 mg/kg followed by continuous infusions of 3 mg/kg/h)
Trial: 15644016
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy for dependent smokers
Trial: 26908742
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of the live attenuated tetravalent dengue vaccine TV003
Trial: 20306535
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil capsules (656 mg daily) - Control
Trial: 19375519
Drug: Oral mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mesalamine 2 g once daily
Trial: 26414912
Drug: one tablet
RxNorm normalized name: Hydone Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: one tablet daily (seven/week)
Trial: 17924872
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g placebo (OGTT(control))
Trial: 24446385
Drug: Exogenous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous insulin (biphasic insulin aspart) administered in relation to meals
Trial: 17638699
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg bevirimat
Trial: 17638699
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg bevirimat
Trial: 6418506
Drug: mannitol solution
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: mannitol solution
Trial: 11673036
Drug: Subconjunctival administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subconjunctival administration of 20 mg vancomycin
Trial: 9037131
Drug: TSH suppressive
RxNorm normalized name: TSH-releasing hormone
DrugBank: Protirelin (DB09421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TSH suppressive treatment
Trial: 3061717
Drug: Captopril administration
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril administration in the supine position
Trial: 21961644
Drug: Five days
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five days oral course of Co-Amoxiclav postoperatively
Trial: 31479549
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg twice weekly
Trial: 7191300
Drug: triamterene preparation
RxNorm normalized name: Triamterene
DrugBank: Triamterene (DB00384)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: triamterene preparation 1
Trial: 31963636
Drug: Oral piercings
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral piercings
Trial: 17242102
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg IV
Trial: 14705234
Drug: Tramadol 37.5
RxNorm normalized name: ACETAMINOPHEN 325MG/TRAMADOL 37.5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 37.5 mg/acetaminophen 325 mg (tramadol/APAP)
Trial: 2966552
Drug: Low-dose isradipine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose isradipine (0.007 mg/kg)
Trial: 2966552
Drug: High-dose isradipine
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose isradipine (0.015 mg/kg)
Trial: 8866920
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg trimethoprim + 200 mg didanosine
Trial: 24623104
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa 30 μg
Trial: 18341417
Drug: Active laser
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active laser treatment (810-nm Ga-Al-As laser, 60 mW, 1.8 J per point, 14.4 J per session, 12 sessions over 8 weeks)
Trial: 18563956
Drug: Intramuscular aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intramuscular aripiprazole (doses from 1 mg to 45 mg)
Trial: 12221387
Drug: Professional oral
RxNorm normalized name: Dentek Professional Oral Care Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professional oral health care (POHC)
Trial: 31096977
Drug: Control program
RxNorm normalized name: ZO Skin Health Pigment Control Program Plus Hydroquinone KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control program (monthly healthy lifestyle education-only)
Trial: 28666848
Drug: propofol 25
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: propofol 25 mcg/kg/h + lidocaine 1 mg/kg/h
Trial: 28666848
Drug: propofol 50
RxNorm normalized name: propofol 500 MG in 50 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propofol 50 mcg/kg/h
Trial: 29499855
Drug: PF-03463275 20
RxNorm normalized name: acetylcysteine
DrugBank: Acetylcysteine magnesium (DB14080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PF-03463275 20 mg twice a day
Trial: 29499855
Drug: PF-03463275 60
RxNorm normalized name: codeine
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PF-03463275 60 mg twice a day
Trial: 27147900
Drug: Three-weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Three-weekly paclitaxel (175 mg/m²)
Trial: 28647788
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg IV-dexamethasone (group dexa)
Trial: 19035877
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg inhaled salbutamol via spacer device (corrected for heart rate)
Trial: 19035877
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg nebulized salbutamol (corrected for heart rate)
Trial: 15663493
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (2000 mg) and Vitamin E (800 IU) daily for 7 days prior to cryotherapy
Trial: 2969930
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg/day
Trial: 26763498
Drug: Written Exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Written Exposure Treatment (WET) for PTSD
Trial: 21559793
Drug: Inhalation anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anesthesia (SEV)
Trial: 25119509
Drug: Multidisciplinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary treatment as usual without PMT
Trial: 21293087
Drug: Losartan potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan potassium (LOS) 50 mg for 4 weeks, then LOS 100 mg for 4 weeks (n = 469)
Trial: 11083963
Drug: Nebulized ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized ipratropium bromide (250 mg per dose) plus nebulized salbutamol (0.2 mg/kg) and oral steroids (1 mg/kg)
Trial: 3092656
Drug: Enprostil 35
RxNorm normalized name: enprostil
DrugBank: Enprostil (DB13824)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprostil 35 micrograms twice daily
Trial: 26496767
Drug: Insulin tolerance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin tolerance test (ITT)
Trial: 8292312
Drug: Comparison group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison group (no treatment)
Trial: 11549425
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) 600 mg/m2 (C)
Trial: 26125735
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (3D‐CRT + adjuvant chemotherapy)
Trial: 8203335
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg three times daily
Trial: 18800460
Drug: lisinopril 20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lisinopril 20 mg
Trial: 6446445
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (1500 mg)